1. Home
  2. RXRX vs AVDL Comparison

RXRX vs AVDL Comparison

Compare RXRX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RXRX
  • AVDL
  • Stock Information
  • Founded
  • RXRX 2013
  • AVDL 2015
  • Country
  • RXRX United States
  • AVDL Ireland
  • Employees
  • RXRX N/A
  • AVDL N/A
  • Industry
  • RXRX Biotechnology: Pharmaceutical Preparations
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RXRX Health Care
  • AVDL Health Care
  • Exchange
  • RXRX Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • RXRX 2.2B
  • AVDL 1.8B
  • IPO Year
  • RXRX 2021
  • AVDL 1996
  • Fundamental
  • Price
  • RXRX $4.20
  • AVDL $23.07
  • Analyst Decision
  • RXRX Buy
  • AVDL Buy
  • Analyst Count
  • RXRX 4
  • AVDL 9
  • Target Price
  • RXRX $7.25
  • AVDL $18.38
  • AVG Volume (30 Days)
  • RXRX 37.2M
  • AVDL 2.7M
  • Earning Date
  • RXRX 11-05-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • RXRX N/A
  • AVDL N/A
  • EPS Growth
  • RXRX N/A
  • AVDL N/A
  • EPS
  • RXRX N/A
  • AVDL N/A
  • Revenue
  • RXRX $43,689,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • RXRX $24.17
  • AVDL $64.21
  • Revenue Next Year
  • RXRX $20.96
  • AVDL $30.80
  • P/E Ratio
  • RXRX N/A
  • AVDL N/A
  • Revenue Growth
  • RXRX N/A
  • AVDL 79.88
  • 52 Week Low
  • RXRX $3.79
  • AVDL $6.38
  • 52 Week High
  • RXRX $12.36
  • AVDL $23.57
  • Technical
  • Relative Strength Index (RSI)
  • RXRX 38.50
  • AVDL 82.66
  • Support Level
  • RXRX $3.81
  • AVDL $18.74
  • Resistance Level
  • RXRX $4.37
  • AVDL $23.28
  • Average True Range (ATR)
  • RXRX 0.35
  • AVDL 0.29
  • MACD
  • RXRX -0.08
  • AVDL 0.28
  • Stochastic Oscillator
  • RXRX 24.83
  • AVDL 89.64

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: